News
H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award ...
The company made the announcement on Wednesday and added they would explore alternatives for late stage development and ...
The Department of Health and Human Service is pulling millions of dollars in funding for a human bird flu vaccine developed ...
Moderna (MRNA) stock trades flat as the U.S. cancels a $766M contract granted for the company to develop a vaccine against ...
Trump Administration Live Updates: Appeals Court Spares Trump’s Tariffs While It Considers Challenge
Taken together, the actions by the Trump administration amount to an aggressive campaign to “decouple” the United States from ...
There are growing concerns that President Trump's depletion of the federal workforce is putting America's farms at risk, which could lead to higher food prices and hurdles for farm exports.
The funding was meant to help the U.S. prepare for pandemics triggered by avian flu strains, but now leaves the future of ...
WASHINGTON: United States President Donald Trump's administration on Wednesday (May 29) canceled a US$590 million contract ...
MRNA technology is already used in Moderna’s and Pfizer/BioNTech’s currently licensed COVID-19 vaccines, which have been found to be safe and effective.
THURSDAY, May 29, 2025 (HealthDay News) — The U.S. government has canceled a $600 million contract with Moderna to develop a vaccine for bird flu and other dangerous flu strains, raising concern among ...
New Product Streamlines Prior Authorization to Improve Patient, Provider, and Payer Outcomes BOSTON, MA / ACCESS Newswire / ...
INDIANAPOLIS, INDIANA / ACCESS Newswire / May 29, 2025 / Dan O’Toole, CEO of Arrive AI (NASDAQ:ARAI), an autonomous delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results